Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Grothe

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Experimental Brain Research|June 6, 2024
The excitability of ipsilateral motor evoked potentials is not task-specific and spatially distinct from the contralateral motor hotspotNelly Seusing, Sebastian Strauss, Robert Fleischmann, et al.
Journal of Neurology|September 4, 2025
Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosisDavid Ellenberger, Niklas Frahm, Alexander Stahmann, et al.
Frontiers in Neurology|November 21, 2022
Performance in information processing speed is associated with parietal white matter tract integrity in multiple sclerosisMatthias Grothe, Katharina Jochem, Sebastian Strauss, et al.
Neurological Research and Practice|June 26, 2026
Inpatient care for people with multiple sclerosis - a secondary data analysis in Germany between 2019 and 2024Sarah Mai Viebahn, Emily Nothnik, Susan Raths, et al.
Brain Sciences|April 21, 2022
Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological DiseasesFranz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2024
Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapseMichael Hecker, Brit Fitzner, Dirk Koczan, et al.
Biomedicines|July 27, 2022
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple SclerosisFranz Felix Konen, Malte Johannes Hannich, Philipp Schwenkenbecher, et al.
Epilepsia|July 7, 2017
Prevalence and outcome of late-onset seizures due to autoimmune etiology: A prospective observational population-based cohort studyFelix von Podewils, Marie Suesse, Julia Geithner, et al.
Journal of Central Nervous System Disease|November 29, 2021
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal FluidFranz F Konen, Philipp Schwenkenbecher, Ulrich Wurster, et al.
European Journal of Neurology|May 18, 2022
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosisDumitru Ciolac, Gabriel Gonzalez-Escamilla, Yaroslav Winter, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Experimental Brain Research|June 6, 2024
The excitability of ipsilateral motor evoked potentials is not task-specific and spatially distinct from the contralateral motor hotspotNelly Seusing, Sebastian Strauss, Robert Fleischmann, et al.
Journal of Neurology|September 4, 2025
Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosisDavid Ellenberger, Niklas Frahm, Alexander Stahmann, et al.
Frontiers in Neurology|November 21, 2022
Performance in information processing speed is associated with parietal white matter tract integrity in multiple sclerosisMatthias Grothe, Katharina Jochem, Sebastian Strauss, et al.
Neurological Research and Practice|June 26, 2026
Inpatient care for people with multiple sclerosis - a secondary data analysis in Germany between 2019 and 2024Sarah Mai Viebahn, Emily Nothnik, Susan Raths, et al.
Brain Sciences|April 21, 2022
Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological DiseasesFranz Felix Konen, Philipp Schwenkenbecher, Konstantin Fritz Jendretzky, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 15, 2024
Differential gene expression in B cells and T helper cells following high-dose glucocorticoid therapy for multiple sclerosis relapseMichael Hecker, Brit Fitzner, Dirk Koczan, et al.
Biomedicines|July 27, 2022
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple SclerosisFranz Felix Konen, Malte Johannes Hannich, Philipp Schwenkenbecher, et al.
Epilepsia|July 7, 2017
Prevalence and outcome of late-onset seizures due to autoimmune etiology: A prospective observational population-based cohort studyFelix von Podewils, Marie Suesse, Julia Geithner, et al.
Journal of Central Nervous System Disease|November 29, 2021
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal FluidFranz F Konen, Philipp Schwenkenbecher, Ulrich Wurster, et al.
European Journal of Neurology|May 18, 2022
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosisDumitru Ciolac, Gabriel Gonzalez-Escamilla, Yaroslav Winter, et al.
Pageof 7